 double-blind placebo-controlled clinic-initiated Canadian trial topical edoxudine cream treatment recurrent genital herpes Canadian Cooperative Study Group Treatment recurrent genital herpes edoxudine cream days patients randomized multicenter double-blind placebo-controlled clinic-initiated trial Lesion tenderness predictive sensitive longer-lasting symptom pain patients placebo times cessation investigator-observed signs lesion-associated signs groin signs women Edoxudine viral men days women days days Loss investigator-observed signs days investigator-observed lesion tenderness lesion signs tenderness women edoxudine Edoxudine well-tolerated reduced several signs herpes women clinical role recurrent genital herpes